NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
Back to search
Official data from USPTO
PROJECT GOLD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROJECT GOLD
ST13
US500000098160589Class
35, 40, 44, 45
Filing
98160589
Registration
7584273
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
12/03/2024
Trademark type
Word
Nice classes
35, 40, 44, 45
Filing date
09/01/2023
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-07-00
First use in commerce
2023-07-00
Drawing code
4
Owner type
03
Owner location
San Francisco, CA
Examiner
DINALLO, KEVIN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Curae Pharma360, Inc.
Angels for Change Inc.
Representatives
Andrew D. Bochner BOCHNER PLLC
Technical classification
Nice Classes
Class 35Class 40Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting the interests of cancer patients by means of public advocacyspecifically access and availability of generic drugs for cancer treatment; Promoting public awareness of supply chain issues of generic cancer treatment drugs by means of public advocacy; Pharmaceutical cost management services and drug utilization review servicesgeneric drugs for cancer treatment; Providing advertisingmarketing and promotional services for the pharmaceutical and medical industrythe manufacture and distribution of generic cancer treatment drugs; Promoting public interest and awareness of availability and accessibility of generic drugs for cancer treatment; Consulting in the field of distributorship services for pharmaceuticalsgeneric drugs for cancer treatment
Class 40
Consulting services in the field of pharmaceutical manufacturinggeneric drugs for cancer treatment
Class 44
Pharmaceutical adviceto facilitate and subsidize access to and availability of generic drugs for cancer treatment; Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticalsgeneric drugs for cancer treatment
Class 45
Providing patient advocate services in the field of cancer treatmentincreasing access to and availability of generic drugs therefor; Providing patient advocate and case management servicescoordinating the procurement and administration of medicationspecifically for generic drugs for cancer treatment; Providing information about legal eligibility requirements for government medical and pharmaceutical programsfor access to and availability of generic drugs for cancer treatment
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/10/2024
PUBO
PUBLISHED FOR OPPOSITION
09/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
08/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
08/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2024
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/03/2024
GNRT
NON-FINAL ACTION E-MAILED
05/03/2024
CNRT
NON-FINAL ACTION WRITTEN
05/03/2024
IUAA
USE AMENDMENT ACCEPTED
05/03/2024
DOCK
ASSIGNED TO EXAMINER
04/30/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/07/2024
IUAF
USE AMENDMENT FILED
02/07/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/27/2023
NWAP
NEW APPLICATION ENTERED
09/05/2023
Continuous trademark protection
Get notified about every new filing that threatens PROJECT GOLD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.